Almirall’s Klisyri receives positive CHMP opinion to extend skin treatment area for actinic keratosis
Actinic keratosis is a chronic skin disease and one of the most common diagnoses in dermatology practices in Europe
Read More
Nov 19, 2026 | News, Regulatory
Actinic keratosis is a chronic skin disease and one of the most common diagnoses in dermatology practices in Europe
Read MoreNov 17, 2026 | News, Regulatory
The flexible dosing schedule has been approved for patients with skin, lung and cervical cancer
Read MoreNov 16, 2026 | News, Regulatory
This rare, chronic autoimmune disease can cause kidney failure if left untreated
Read MoreNov 3, 2026 | News, Regulatory
The merger is not final and other companies will be able to bid for Karyopharm’s assets
Read MoreOct 28, 2026 | News, Regulatory
Plaque psoriasis is an inflammatory condition that causes red, scaly and often itchy or painful patches of skin
Read MoreSep 30, 2026 | News, Regulatory
If approved, this treatment would offer a new option for the nearly one million Americans living with MS
Read MoreSep 29, 2026 | News, Regulatory
Desmoid tumours are rare soft tissue tumours that can grow aggressively into nearby tissues
Read MoreSep 28, 2026 | News, Regulatory
Treatment with Olumiant resulted in substantial scalp hair regrowth, as well as improvements in eyebrows and eyelashes
Read MoreSep 25, 2026 | News, Regulatory
The treatment is for adults in combination with atezolizumab
Read MoreSep 23, 2026 | News, Regulatory
Trixeo is the first and only triple-combination therapy approved in the EU for patients 12 years and older, independent of exacerbation history
Read MoreSep 21, 2026 | News, Regulatory
If approved, this would be the first IL-17A inhibitor licensed in Europe for adults with polymyalgia rheumatica
Read MoreSep 15, 2026 | News, Regulatory
Around 33,000 people in the UK are currently living with multiple myeloma, an incurable type of blood cancer
Read More
